New injections aim to control hepatitis b – early trial underway

NCT ID NCT07183306

First seen Oct 31, 2025 · Last updated May 11, 2026 · Updated 29 times

Summary

This study tests two experimental injections (HT-101 and HT-102) in about 86 people with chronic hepatitis B. Participants also take standard antiviral pills. The main goals are to check safety and how the body processes the drugs. This is an early-phase trial, so it focuses on safety and dosing, not yet on a cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Beijing Ditan Hospital Capital Medical University

    Beijing, Beijing Municipality, 100015, China

  • Guangzhou Eighth People's Hospital, Guangzhou Medical University

    Guangzhou, Guangdong, 510440, China

  • Nanfang Hospital

    Guangzhou, Guangdong, 510515, China

  • Qingyuan People's Hospital

    Qingyuan, Guangdong, 511518, China

  • Shanghai Public Health Clinical Center

    Shanghai, Shanghai Municipality, 200083, China

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, 610072, China

  • Xiamen Hospital of Traditional Chinese Medicine

    Xiamen, Fujian, 361001, China

Conditions

Explore the condition pages connected to this study.